- Report
- July 2019
- 250 Pages
United States
From €2195EUR$2,300USD£1,867GBP
- Report
- July 2019
- 251 Pages
United Kingdom
From €2195EUR$2,300USD£1,867GBP
- Report
- July 2019
- 250 Pages
Spain
From €2195EUR$2,300USD£1,867GBP
- Report
- July 2019
- 250 Pages
Japan
From €2195EUR$2,300USD£1,867GBP
- Report
- July 2019
- 250 Pages
Italy
From €2195EUR$2,300USD£1,867GBP
- Report
- July 2019
- 250 Pages
Germany
From €2195EUR$2,300USD£1,867GBP
From €1765EUR$1,850USD£1,502GBP
- Report
- December 2023
- 221 Pages
Global
From €2671EUR$2,799USD£2,272GBP
The AIDS Test market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of HIV, the virus that causes AIDS. Tests are used to diagnose HIV infection, monitor the progression of the virus, and assess the effectiveness of treatments. Tests are available in a variety of formats, including blood tests, oral swabs, and urine tests.
The AIDS Test market is highly competitive, with a number of companies offering a range of products. These include Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson, Cepheid, DiaSorin, Hologic, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more